Wednesday, December 13, 2017
In recent months we are hearing more and more of traditionally tech companies staking out new ground in the land of big pharma.
In the US, the ever increasing amounts spent on branded drugs is a serious issue.
Since 2000, many branded drugs in the US have experienced rapid annual price increases.